Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XBiotech Inc. Director's Dealing 2024

Jun 21, 2024

34229_dirs_2024-06-21_eea28960-f944-404d-9b02-b655d4e74ef1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2024-06-20

Reporting Person: Waldin Jan-Paul (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-06-20 Director Stock Option $5.12 A 37500 Acquired 2034-06-20 Common Stock (37500) Direct